Out-licensing creates an opportunity for the companies to develop their portfolio, to gain massive and rapid ROI. Aconitum developed 4 valuable CTD out-licensing products, and we are also open to explore out-licensing for our products in different territories.
| Substance, strength | Form | Dossier type | Registration status |
| Silymarin 140 mg (from Milk thistle (Silybum marianum) extract) | hard capsules | Bibliographic | Registered in Lithuania, Vietnam |
| Vinpocetine 5 mg / 10 mg | tablet | Bibliographic | Registered in Lithuania, Vietnam, Bulgaria, Bosnia and Herzegovina, Serbia |
| Vinpocetine 5 mg / 10 mg | hard capsules | Bibliographic | Registered in Lithuania |
| Ginkgo extract (Ginkgo biloba) 80 mg / 120 mg | hard capsules | Bibliographic | Registered in Lithuania, Vietnam |